Myriad Genetics | MYGN - Gross Profit On Sales

Stock Price
5.12
Daily Change
0.02 0.39%
Monthly
-22.78%
Yearly
-58.74%
Q1 Forecast
5.45

Myriad Genetics reported $143.8M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Agilent USD 990M 102M Sep/2025
Becton, Dickinson and Co. USD 696M 1.94B Sep/2025
Bio-Rad Laboratories USD 345.3M 34.7M Jun/2025
Bruker USD 379.4M 21.5M Sep/2025
Danaher USD 3.97B 443M Dec/2025
Exact Sciences USD 583.93M 21.48M Sep/2025
Hologic USD 586.4M 2.9M Dec/2025
Illumina USD 759M 26M Dec/2025
J&J USD 16.6B 118M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 143.8M 8M Sep/2025
Quest Diagnostics USD 910M 6M Sep/2025
Quidel USD -733M 1.01B Sep/2025
Repligen USD 100.52M 9.37M Sep/2025
Revvity USD 374.6M 17.95M Sep/2025
Standard Biotools USD 9.48M 1.15M Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Veracyte USD 91.28M 1.51M Sep/2025
Waters USD 459.99M 21.97M Sep/2025